These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21851425)
1. Acral lesions of vitiligo: why are they resistant to photochemotherapy? Esmat SM; El-Tawdy AM; Hafez GA; Zeid OA; Abdel Halim DM; Saleh MA; Leheta TM; Elmofty M J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1097-104. PubMed ID: 21851425 [TBL] [Abstract][Full Text] [Related]
2. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999 [TBL] [Abstract][Full Text] [Related]
3. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis. Seleit I; Bakry OA; Abdou AG; Dawoud NM Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443 [TBL] [Abstract][Full Text] [Related]
5. [Repigmentation of vitiligo induced by oral photochemotherapy. Histoenzymological and ultrastructural study (author's transl)]. Ortonne JP; MacDonald DM; Micoud A; Thivolet J Ann Dermatol Venereol; 1978 Nov; 105(11):939-40. PubMed ID: 754609 [TBL] [Abstract][Full Text] [Related]
6. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo. Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578 [TBL] [Abstract][Full Text] [Related]
13. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. Ortonne JP; Schmitt D; Thivolet J J Invest Dermatol; 1980 Jan; 74(1):40-2. PubMed ID: 7351492 [TBL] [Abstract][Full Text] [Related]
14. Clinical and histopathologic characteristics of trichrome vitiligo. Hann SK; Kim YS; Yoo JH; Chun YS J Am Acad Dermatol; 2000 Apr; 42(4):589-96. PubMed ID: 10727303 [TBL] [Abstract][Full Text] [Related]
15. Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-acral lesions of non-segmental vitiligo patients: a follow-up-based study in North India. Nayak D; Srivastava N; Dev A; Bishnoi A; Kumaran MS; Vinay K; Parsad D Arch Dermatol Res; 2023 Sep; 315(7):2003-2009. PubMed ID: 36877308 [TBL] [Abstract][Full Text] [Related]
16. Response of vitiligo to PUVA therapy in Saudi patients. Tallab T; Joharji H; Bahamdan K; Karkashan E; Mourad M; Ibrahim K Int J Dermatol; 2005 Jul; 44(7):556-8. PubMed ID: 15985023 [TBL] [Abstract][Full Text] [Related]
17. Recent onset vitiligo on acral areas treated with phototherapy: need of early treatment. Lee DY; Kim CR; Lee JH Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):266-8. PubMed ID: 21175856 [TBL] [Abstract][Full Text] [Related]
18. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo. Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028 [TBL] [Abstract][Full Text] [Related]
19. Update on skin repigmentation therapies in vitiligo. Falabella R; Barona MI Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503 [TBL] [Abstract][Full Text] [Related]
20. A randomized prospective study to assess the role of topical tacrolimus as preventive therapy in unstable acral vitiligo. Kumar D; Thakur V; Subburaj K; Bishnoi A; Vinay K; Sendhil Kumaran M; Parsad D J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2243-2248. PubMed ID: 37467136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]